Session Item

Systematic monitoring of late effects from radiotherapy is important in determining normal tissue effects and measuring dose response. Patient reported outcome (PRO) enable us to record patient perceptions of the impact of their cancer and the consequences of treatment. This talk will begin with a background on defining patient PRO and what is expected of a PRO tool. The differences between PRO describing the continuum of general and specific PRO tools and the requirement to use combinations to capture a range of PRO concepts will be discussed. The importance of collaborating with patients to tailor PRO which are most relevant to future patients will be highlighted using examples from breast radiotherapy trials. Finally, methods to optimise and streamline PRO using the most relevant questions and reduce missing data will be mentioned.